Dr. Christopher Clayton Porter MD
Hematologist (Pediatric) | Pediatric Hematology-Oncology
1056 E 19th Ave Denver CO, 80218About
Dr. Christopher Porter is a pediatric hematologist practicing in Denver, CO. Dr. Porter specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Porter treats include leukemias, lymphomas and certain tumors. Dr. Porter can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
Rush Med Coll of Rush Univ, Chicago Il 1990
Board Certification
UrologyAmerican Board of UrologyABU
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Influenza immunization practices among pediatric oncologists.
- Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia.
- Impaired DNA replication within progenitor cell pools promotes leukemogenesis.
- Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature.
- Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.
- BCL6 expression correlates with monomorphic histology in children with posttransplantation lymphoproliferative disease.
- Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
- Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A.
- Irradiation selects for p53-deficient hematopoietic progenitors.
- Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.
- Targeting developmental pathways in children with cancer: what price success?
- Knockdown of HPRT for selection of genetically modified human hematopoietic progenitor cells.
- Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality.
- STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious.
- Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.
Dr. Christopher Clayton Porter MD's Practice location
Dr. Christopher Clayton Porter MD's reviews
Write ReviewRecommended Articles
- How Do High Cholesterol Levels Affect the Heart?
How Do High Cholesterol Levels Affect the Heart?Cholesterol is not that bad for our body – it has several important functions and is needed in moderate amounts. This compound is required to make new cells in the body, protect neurons, and also produce hormones. But when the amount of cholesterol...
- Autism: A Life-Saving Database
One of the biggest concerns facing families of children or adults with autism or Alzheimer’s disease is how to prevent wandering. ...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...